Free Cardiology CME 2017‑2018 | CMEList.com

 


Cardiovascular Disease, Diabetes, and Diabetes Treatments: Understanding the Interrelationships
Free Cardiology CME Free Diiabetes CME Live online March 1, 2017, (Sessions 1 and 2), and March 29, 2017 (Session 3), and available on demand through September 29 2017.
Posted by...Bernard Sklar, MD.
Free Cardiovascular and Diabetes CME Credit hours...3.0.
CME Credits Awarded by....University of Cincinnati.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for primary care clinicians, diabetes specialists, cardiologists, as well as other health care providers who provide front-line glycemic management for type 2 diabetes (T2DM) and its comorbidities.
Educational material updated...March 29, 2017.
Expiration of CME credit...September 29 2017.
Financial Support...Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC, and Novo Nordisk Inc.
This activity consists of three sessions, each of which should take approximately 1 hour to complete.
At the conclusion of Cardiovascular Disease, Diabetes, and Diabetes Treatments, you will be able to:
• Discuss the etiologic and pathophysiologic interconnections among the components of the cardiometabolic syndrome and the development of cardiovascular disease
• Identify pharmacological actions of antidiabetes medications that could potentially impact cardiovascular outcomes
• Describe the rationale for studying the cardiovascular impact of antidiabetes medications
• Compare and contrast antidiabetes pharmacotherapies which can optimize glycemic control and minimize adverse effects on cardiovascular risk and/or disease
• Discuss the efficacy and safety data for recent trials that examined the cardiovascular impact of antidiabetes medications
• Delineate critical assessments of recent cardiovascular outcomes trials for antidiabetes medications with regard to their evidence-based clinical implications

Anticoagulation in The Era of Newer Target-Specific Oral Agents Free Cardiology CME
Live online October 7, 2016, and available on demand through April 7, 2017.
Posted by...Bernard Sklar, MD.
Free Cardiology CME Credit hours...1.0.
CME Credits Awarded by....Albert Einstein College of Medicine and Montefiore Medical Center.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for Cardiologists, emergency department specialists, intensive care specialists, surgeons, hospitalists, internists, primary care physicians, nurse practitioners, physician assistants, nurses, pharmacists, and other health care professionals caring for patients requiring antithrombotic therapy.
Educational material updated... October 7, 2016.
Expiration of CME credit... April 7, 2017.
Financial Support...Boehringer Ingelheim Pharmaceuticals, Inc. and Daiichi-Sankyo.
At the conclusion of Anticoagulation in The Era of Newer Target-Specific Oral Agents, you will be able to:
• Identify barriers to achieving guideline-recommended anticoagulation
• Assess the safety profiles of NOACs compared with warfarin in multiple disease settings, including atrial fibrillation, venous thromboembolism, and pulmonary embolism
• Compare and contrast the administration, clinical efficacy, and safety of antidotes for the reversal of anticoagulant effects of warfarin and NOACs in patients who require emergency anticoagulation reversal

Advances in Heart Failure Management: Improving Outcomes with Innovation Frree Cardiology CME
Live online September 27, 2016, and November 1, 2016 and available on demand through May 1, 2017.
Posted by...Bernard Sklar, MD.
Free Cardiology CME Credit hours...3.0.
CME Credits Awarded by....Postgraduate Institute for Medicine.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for cardiologists, interventional cardiologists, internal medicine and primary care physicians, and other health care professionals who treat patients with heart failure.
Educational material updated... June 9, 2016.
Expiration of CME credit... May 1, 2017.
Financial Support...Novartis Pharmaceutical Corporation.
At the conclusion of Advances in Heart Failure Management, you will be able to:
• Implement heart failure classification systems, such as the ACC/AHA stages or NYHA functional classification, in order to effectively stage patients and direct treatment goals
• Evaluate the role of biomarkers as prognostic indicators, and to monitor therapy for patients with reduced or preserved ejection fraction heart failure
• Implement pivotal study data for recently approved therapies for patients with heart failure
• Evaluate pivotal study data for recently approved therapies for patients with heart failure
• Implement electricity and catheter-based therapies for heart failure patients who are appropriate candidates
• Appraise clinical trial data for emerging interventions for patients with advanced heart failure
• Compare and contrast clinical trial data for emerging therapies and interventions
• Prescribe evidence-based approaches to real heart failure cases

Hyperkalemia: Causes, Consequences, and Treatment
Free Hyperkalemia CME Posted by...Bernard Sklar, MD.
Free CME Credit Hours...0.75.
CME Credits Awarded by...Vindico Medical Education.
Cost for Credit...Free.
Instruction Type...Video Lectures.
Target Audience...Nephrologists, endocrinologists, cardiologists, internal medicine physicians, primary care physicians and other health care professionals involved in the treatment of patients with hyperkalemia.
Educational material last updated...December 14, 2016.
CME Credit Expires...December 13, 2017.
Financial Support...Relypsa, Inc.
Hyperkalemia: Causes, Consequences, and Treatment consists of three brief video presentations on hyperkalemia.
Upon successful completion of Hyperkalemia: Causes, Consequences, and Treatment, you should be better able to:
• Describe the pathophysiology of hyperkalemia, etiologic factors associated with its presentation, and its potential effect on multiple organ systems.
• Review the symptoms that commonly present in patients with hyperkalemia to assist in determining the appropriate diagnostic follow-up.
Differentiate among the new and emerging agents for hyperkalemia for improved treatment selection.
• Apply the efficacy and safety data of conventional therapy and emerging treatments when selecting therapy for hyperkalemia in patients with chronic kidney disease or end-stage renal disease and chronic heart failure.
• Select the appropriate treatment for patients with diabetes and hyperkalemia.

SGLT-2 Inhibitors in the Treatment of Type 2 Diabetes: Methodology and Monitoring Impact Type 2 Diabetes CME
Live online August 10, 2016, and available on demand through February 10, 2017.
Posted by...Bernard Sklar, MD.
Free Diabetes CME Credit hours...1.0.
CME Credits Awarded by....Primary Care Network.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for primary care clinicians and other health care providers, such as cardiologists and nephrologists, who provide front-line glycemic management for type 2 diabetes and related conditions.
Educational material updated...August 10, 2016. 
Expiration of CME credit...February 10, 2017.  
Financial Support...This activity is not supported by any commercial interest or grantors.
At the conclusion of SGLT-2 Inhibitors in the Treatment of Type 2 Diabetes, you will be able to:
• Describe how the kidney - and, specifically, SGLT-2 - normally play a physiologic role in the regulation of glycemia, and how those functions can be targeted as part of the treatment of hyperglycemia in type 2 diabetes
• Discuss how SGLT2 inhibitors can be integrated into a comprehensive glycemic treatment program for type 2 diabetes by leveraging their mechanisms of pharmacotherapeutic action, indications, methods for initiation and titration, and adverse effect monitoring
• Delineate a balanced approach to assessing the risk/benefit ratio of SGLT2 inhibitors so as to optimally and safely utilize them when indicated to achieve therapeutic goals

How Low Can You Go? LDL - Is Lower Really Better?
Posted by...Bernard Sklar, MD. cholesterol CME
Free CME Credit Hours...1.0.
CME Credits Awarded by...Vindico Medical Education.
Cost for Credit...Free.
Instruction Type...Video Lectures.
Target Audience...Cardiologists, endocrinologists, primary care physicians, family physicians, internists, and other health care professionals involved in the treatment of patients with dyslipidemia.
Educational material last updated...August 25, 2016.
CME Credit Expires...August 24, 2017.
Financial Support...Amgen.
How Low Can You Go? LDL - Is Lower Really Better?  features interviews with clinical experts, who discuss newly released evidence and guidelines regarding cardiovascular risk assessment, best practices when evaluating patients with elevated LDL-C, clinical study data pertaining to the effects of lowering LDL-C beyond evidence-based recommendations, and use of non-statin therapies for the treatment of dyslipidemia in patients who cannot achieve desired target levels.
Upon successful completion of How Low Can You Go? LDL - Is Lower Really Better?, you should be better able to:
• Incorporate cardiovascular risk assessment, evidence-based guidelines, and best practices when evaluating patients with elevated LDL-C.
• Assess clinical study data pertaining to the effect of lowering LDL-C beyond evidence-based recommendations and its effect on cardiovascular risk reduction.
• Evaluate the use of non-statin therapies for the treatment of dyslipidemia in patients who are intolerant or in patients who cannot achieve desired target levels. • Incorporate therapeutic regimens with demonstrated ability to reduce risk markers other than LDL-C.
• Incorporate therapeutic regimens with demonstrated ability to reduce risk markers other than LDL-C.

ScientiaCME Cardiology/Pulmonology Free Cardiology CME ScientiaCME Cardiology/Pulmonology
Posted by...Bernard Sklar, MD.
CME Credit Hours...2.0.
CME Credits Awarded by....ScientiaCME.
Cost...........Free.
Instruction Type...Slide-Video Lectures.
Target Audience...CARDIOLOGY, CHEST MEDICINE, FAMILY MEDICINE, INTERNAL MEDICINE.
CME Credit Expires...Two years after release.
Financial Support...Various commercial supporters.

ScientiaCME Treatment strategies in Gaucher disease Free Gaucher Disease CME
CME Credit Hours...1.25.
CME Credits Awarded by....ScientiaCME.
Cost...........Free.
Instruction Type...Slide-Video Lectures.
Target Audience...Cardiology, genetic disorders, hematology, oncology, orthopedics, gastroenterology, neurology and pediatrics.
Educational material updated....February 12, 2017.
Expiration of CME credit...February 12, 2019.
Financial Support...Shire.
At the conclusion of By the end of Treatment strategies in Gaucher disease, you will be able to:
• Describe the importance of appropriate GD (Gaucher Disease) diagnosis and treatment (use • for bullets)
• Determine the likelihood of GD using with established diagnosis methods, given a patient case
• Describe present therapies for the treatment of GD and the literature supporting their use
• Design a medical plan to treat a patient with GD, taking into account presently available therapies